On Friday, Theriva Biologics Inc (AMEX: TOVX) was -6.66% drop from the session before settling in for the closing price of $0.24. A 52-week range for TOVX has been $0.20 – $2.08.
Annual sales at Healthcare sector company grew by 39.99% over the past five years. When this article was written, the company’s average yearly earnings per share was at 80.61%. With a float of $32.97 million, this company’s outstanding shares have now reached $33.74 million.
Theriva Biologics Inc (TOVX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Theriva Biologics Inc stocks. The insider ownership of Theriva Biologics Inc is 2.27%, while institutional ownership is 1.30%.
Theriva Biologics Inc (TOVX) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -11.49 earnings per share (EPS) during the time that was less than consensus figure (set at -7.22) by -4.27. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 80.61% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 51.81% during the next five years compared to 39.99% growth over the previous five years of trading.
Theriva Biologics Inc (AMEX: TOVX) Trading Performance Indicators
You can see what Theriva Biologics Inc (TOVX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.54, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -2.28 in one year’s time.
Technical Analysis of Theriva Biologics Inc (TOVX)
Theriva Biologics Inc (AMEX: TOVX) saw its 5-day average volume 4.37 million, a negative change from its year-to-date volume of 4.68 million. As of the previous 9 days, the stock’s Stochastic %D was 32.49%.
During the past 100 days, Theriva Biologics Inc’s (TOVX) raw stochastic average was set at 4.13%, which indicates a significant decrease from 36.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0328 in the past 14 days, which was lower than the 0.0436 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3334, while its 200-day Moving Average is $0.6411. Nevertheless, the first resistance level for the watch stands at $0.2474 in the near term. At $0.2693, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.2880. If the price goes on to break the first support level at $0.2068, it is likely to go to the next support level at $0.1881. The third support level lies at $0.1662 if the price breaches the second support level.
Theriva Biologics Inc (AMEX: TOVX) Key Stats
There are 33,740K outstanding shares of the company, which has a market capitalization of 7.61 million. As of now, sales total 0 K while income totals -25,650 K. Its latest quarter income was 0 K while its last quarter net income were -4,360 K.
